| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.903 | 0.004 | 0.903 | Anticonvulsant | |||
| 0.776 | 0.002 | 0.776 | GABA receptor antagonist | |||
| 0.77 | 0.002 | 0.77 | GABA A receptor antagonist | |||
| 0.762 | 0.002 | 0.762 | Benzodiazepine agonist | |||
| 0.71 | 0.003 | 0.71 | GABA receptor agonist | |||
| 0.618 | 0.004 | 0.618 | Anesthetic general | 0.379 0.019 DBMET00648 | ||
| 0.611 | 0.006 | 0.611 | GABA C receptor rho-3 antagonist | |||
| 0.567 | 0.007 | 0.567 | Psychostimulant | 0.279 0.049 DBMET00648 | ||
| 0.426 | 0.016 | 0.426 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.303 | 0.004 | 0.303 | Potassium channel activator | |||
| 0.282 | 0.007 | 0.282 | GABA C receptor rho-2 antagonist | |||
| 0.293 | 0.036 | 0.293 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.294 | 0.038 | 0.294 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.23 | 0.002 | 0.23 | Benzodiazepine receptor peripheral-type antagonist | 0.049 0.007 DBMET00648 | ||
| 0.212 | 0.005 | 0.212 | Cyclin B3 inhibitor | |||
| 0.353 | 0.147 | 0.353 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.213 | 0.01 | 0.213 | Interleukin 8 antagonist | |||
| 0.223 | 0.022 | 0.223 | Death-associated protein kinase 2 inhibitor | |||
| 0.241 | 0.056 | 0.241 | RNA-directed DNA polymerase inhibitor | 0.212 0.083 DBMET00648 | ||
| 0.246 | 0.062 | 0.246 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.192 | 0.016 | 0.192 | Protein kinase C gamma inhibitor | |||
| 0.175 | 0.015 | 0.175 | Protein kinase C zeta inhibitor | |||
| 0.176 | 0.019 | 0.176 | GABA C receptor antagonist | |||
| 0.15 | 0.003 | 0.15 | Benzodiazepine antagonist | |||
| 0.303 | 0.161 | 0.333 | 5 Hydroxytryptamine release inhibitor | 0.333 0.131 DBMET00648 | DBMET00648 | |
| 0.175 | 0.035 | 0.175 | Glutamate receptor antagonist | |||
| 0.154 | 0.02 | 0.154 | GABA C receptor rho-1 antagonist | |||
| 0.223 | 0.091 | 0.223 | Aryl hydrocarbon receptor agonist | |||
| 0.15 | 0.025 | 0.286 | Beta glucuronidase inhibitor | 0.286 0.007 DBMET00648 | DBMET00648 | |
| 0.13 | 0.013 | 0.157 | Glycine receptor antagonist | 0.157 0.006 DBMET00648 | DBMET00648 | |
| 0.142 | 0.027 | 0.142 | NMDA receptor antagonist | |||
| 0.118 | 0.009 | 0.118 | NMDA receptor glycine site agonist | |||
| 0.131 | 0.029 | 0.131 | Electrolyte absorption antagonist | |||
| 0.1 | 0.008 | 0.1 | Cholecystokinin antagonist | |||
| 0.193 | 0.102 | 0.193 | Nitric-oxide synthase stimulant | |||
| 0.154 | 0.065 | 0.18 | Lipid peroxidase inhibitor | 0.18 0.051 DBMET00648 | DBMET00648 | |
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | |||
| 0.092 | 0.008 | 0.092 | Kainate receptor antagonist | |||
| 0.101 | 0.019 | 0.101 | NMDA receptor agonist | |||
| 0.146 | 0.073 | 0.146 | MAP kinase 3 inhibitor | |||
| 0.131 | 0.058 | 0.131 | MAP kinase 12 inhibitor | |||
| 0.144 | 0.075 | 0.144 | MAP kinase kinase 4 inhibitor | |||
| 0.081 | 0.014 | 0.081 | Cyclin B2 inhibitor | |||
| 0.088 | 0.021 | 0.088 | Plasminogen activator inhibitor | |||
| 0.154 | 0.088 | 0.154 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.119 | 0.056 | 0.119 | MAP kinase 13 inhibitor | |||
| 0.155 | 0.093 | 0.304 | ATPase inhibitor | 0.304 0.005 DBMET00648 | DBMET00648 | |
| 0.085 | 0.024 | 0.085 | Protein kinase C beta inhibitor | |||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | |||
| 0.083 | 0.022 | 0.083 | Protein kinase C eta inhibitor | |||
| 0.075 | 0.019 | 0.075 | AMPA receptor antagonist | |||
| 0.074 | 0.018 | 0.074 | Cyclin B inhibitor | |||
| 0.176 | 0.122 | 0.176 | ErbB-1 antagonist | |||
| 0.134 | 0.08 | 0.134 | Protein kinase C nu inhibitor | |||
| 0.058 | 0.005 | 0.058 | NMDA receptor glycine site antagonist | |||
| 0.134 | 0.081 | 0.245 | Cell wall synthesis inhibitor | 0.245 0.017 DBMET00648 | DBMET00648 | |
| 0.135 | 0.085 | 0.135 | Pregnane X receptor agonist | |||
| 0.24 | 0.192 | 0.24 | Analgesic | |||
| 0.154 | 0.108 | 0.154 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.18 | 0.134 | 0.18 | DNA damaging | 0.174 0.141 DBMET00648 | ||
| 0.063 | 0.018 | 0.063 | NMDA receptor subunit 3B antagonist | |||
| 0.098 | 0.056 | 0.139 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.139 0.03 DBMET00648 | DBMET00648 | |
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.149 | 0.109 | 0.149 | Catenin beta inhibitor | 0.139 0.134 DBMET00648 | ||
| 0.097 | 0.059 | 0.097 | Protein kinase C mu inhibitor | |||
| 0.052 | 0.015 | 0.052 | Kainate receptor 2 antagonist | |||
| 0.072 | 0.034 | 0.072 | MDM2 inhibitor | |||
| 0.177 | 0.142 | 0.354 | Interleukin agonist | 0.354 0.028 DBMET00648 | DBMET00648 | |
| 0.045 | 0.01 | 0.045 | Cyclin E2 inhibitor | |||
| 0.173 | 0.139 | 0.421 | Antioxidant | 0.421 0.031 DBMET00648 | DBMET00648 | |
| 0.037 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET00648 | ||
| 0.044 | 0.012 | 0.044 | Cholecystokinin B antagonist | |||
| 0.138 | 0.109 | 0.164 | Interleukin 6 antagonist | 0.164 0.07 DBMET00648 | DBMET00648 | |
| 0.054 | 0.028 | 0.11 | Phosphorylase inhibitor | 0.11 0.012 DBMET00648 | DBMET00648 | |
| 0.148 | 0.123 | 0.148 | MAP kinase kinase 2 inhibitor | |||
| 0.086 | 0.063 | 0.182 | NADH dehydrogenase inhibitor | 0.182 0.012 DBMET00648 | DBMET00648 | |
| 0.062 | 0.042 | 0.062 | Cannabinoid CB1 receptor antagonist | |||
| 0.043 | 0.023 | 0.043 | NMDA receptor subunit 3A antagonist | |||
| 0.045 | 0.026 | 0.045 | GABA B receptor antagonist | |||
| 0.09 | 0.072 | 0.09 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Estrogen-related receptor beta antagonist | |||
| 0.059 | 0.048 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.04 | 0.029 | 0.04 | Acid-sensing ion channel blocker | |||
| 0.034 | 0.024 | 0.034 | Factor XI inhibitor | |||
| 0.057 | 0.048 | 0.057 | Cyclin D1 inhibitor | |||
| 0.061 | 0.053 | 0.061 | Kallikrein 7 inhibitor | |||
| 0.14 | 0.132 | 0.14 | Succinate dehydrogenase inhibitor | |||
| 0.044 | 0.037 | 0.044 | Benzodiazepine inverse agonist | |||
| 0.127 | 0.124 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.022 | 0.02 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DBMET00648 | DBMET00648 | |
| 0.062 | 0.061 | 0.062 | Prostaglandin-E synthase inhibitor | |||
| 0.105 | 0.107 | 0.145 | Alkaline phosphatase inhibitor | 0.145 0.063 DBMET00648 | DBMET00648 | |
| 0.023 | 0.035 | 0.092 | Trypsin I inhibitor | 0.092 0.007 DBMET00648 | DBMET00648 | |
| 0.054 | 0.069 | 0.102 | Trypsin inhibitor | 0.102 0.016 DBMET00648 | DBMET00648 | |
| 0.145 | 0.162 | 0.231 | Cyclic AMP phosphodiesterase inhibitor | 0.231 0.073 DBMET00648 | DBMET00648 | |
| 0.125 | 0.149 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.118 DBMET00648 | DBMET00648 | |
| 0.072 | 0.106 | 0.167 | UDP-glucose 4-epimerase inhibitor | 0.167 0.024 DBMET00648 | DBMET00648 | |
| 0.102 | 0.141 | 0.219 | Mannose-6-phosphate isomerase inhibitor | 0.219 0.021 DBMET00648 | DBMET00648 | |
| 0.016 | 0.056 | 0.105 | Factor X inhibitor | 0.105 0.01 DBMET00648 | DBMET00648 | |
| 0.019 | 0.068 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.014 DBMET00648 | DBMET00648 | |
| 0.073 | 0.122 | 0.115 | Glutamate release inhibitor | 0.115 0.026 DBMET00648 | DBMET00648 | |
| 0.035 | 0.093 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.031 DBMET00648 | DBMET00648 | |
| 0.063 | 0.139 | 0.128 | DNA intercalator | 0.128 0.053 DBMET00648 | DBMET00648 | |
| 0.099 | 0.175 | 0.226 | Hemostatic | 0.226 0.025 DBMET00648 | DBMET00648 | |
| 0.218 | 0.295 | 0.368 | Caspase 9 stimulant | 0.368 0.132 DBMET00648 | DBMET00648 | |
| 0.049 | 0.13 | 0.067 | Glycine receptor agonist | 0.067 0.061 DBMET00648 | DBMET00648 | |
| 0.051 | 0.139 | 0.224 | Topoisomerase I inhibitor | 0.224 0.021 DBMET00648 | DBMET00648 | |
| 0.143 | 0.235 | 0.469 | Cholesterol antagonist | 0.469 0.038 DBMET00648 | DBMET00648 | |
| 0.089 | 0.182 | 0.162 | DNA repair enzyme inhibitor | 0.162 0.022 DBMET00648 | DBMET00648 | |
| 0.038 | 0.144 | 0.146 | Topoisomerase II alpha inhibitor | 0.146 0.024 DBMET00648 | DBMET00648 | |
| 0.133 | 0.249 | 0.365 | Peptidyltransferase inhibitor | 0.365 0.01 DBMET00648 | DBMET00648 | |
| 0.011 | 0.13 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.039 0.007 DBMET00648 | DBMET00648 | |
| 0.13 | 0.252 | 0.237 | DNA synthesis inhibitor | 0.237 0.076 DBMET00648 | DBMET00648 | |
| 0.028 | 0.156 | 0.084 | Heparanase inhibitor | 0.084 0.005 DBMET00648 | DBMET00648 | |
| 0.061 | 0.195 | 0.134 | Alpha-N-acetylglucosaminidase inhibitor | 0.134 0.065 DBMET00648 | DBMET00648 | |
| 0.008 | 0.148 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | 0.05 0.006 DBMET00648 | DBMET00648 | |
| 0.145 | 0.298 | 0.315 | Histamine release inhibitor | 0.315 0.116 DBMET00648 | DBMET00648 | |
| 0.02 | 0.174 | 0.099 | Antineoplastic antibiotic | 0.099 0.047 DBMET00648 | DBMET00648 | |
| 0.047 | 0.208 | 0.085 | Triose-phosphate isomerase inhibitor | 0.085 0.067 DBMET00648 | DBMET00648 | |
| 0.05 | 0.218 | 0.151 | AMP-activated protein kinase stimulant | 0.151 0.028 DBMET00648 | DBMET00648 | |
| 0.034 | 0.202 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 DBMET00648 | DBMET00648 | |
| 0.017 | 0.21 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.083 0.018 DBMET00648 | DBMET00648 | |
| 0.017 | 0.216 | 0.066 | Phosphofructokinase-1 inhibitor | 0.066 0.051 DBMET00648 | DBMET00648 | |
| 0.072 | 0.301 | 0.373 | Free radical scavenger | 0.373 0.034 DBMET00648 | DBMET00648 | |
| 0.041 | 0.277 | 0.14 | Amylase inhibitor | 0.14 0.069 DBMET00648 | DBMET00648 | |
| 0.032 | 0.275 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 DBMET00648 | DBMET00648 | |
| 0.072 | 0.328 | 0.146 | Interferon gamma antagonist | 0.146 0.083 DBMET00648 | DBMET00648 | |
| 0.059 | 0.318 | 0.187 | Hexokinase inhibitor | 0.187 0.043 DBMET00648 | DBMET00648 | |
| 0.113 | 0.381 | 0.323 | Apoptosis antagonist | 0.323 0.07 DBMET00648 | DBMET00648 | |
| 0.109 | 0.377 | 0.514 | Antibacterial | 0.514 0.037 DBMET00648 | DBMET00648 | |
| 0.093 | 0.365 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 DBMET00648 | DBMET00648 | |
| 0.007 | 0.296 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DBMET00648 | DBMET00648 | |
| 0.033 | 0.321 | 0.059 | Lipocortins synthesis agonist | 0.059 0.039 DBMET00648 | DBMET00648 | |
| 0.062 | 0.355 | 0.22 | Non-steroidal antiinflammatory agent | 0.22 0.057 DBMET00648 | DBMET00648 | |
| 0.053 | 0.35 | 0.167 | DNA methyltransferase I inhibitor | 0.167 0.089 DBMET00648 | DBMET00648 | |
| 0.086 | 0.382 | 0.412 | Antithrombotic | 0.412 0.046 DBMET00648 | DBMET00648 | |
| 0.112 | 0.425 | 0.351 | Interleukin 2 agonist | 0.351 0.045 DBMET00648 | DBMET00648 | |
| 0.102 | 0.421 | 0.258 | Caspase 3 stimulant | 0.258 0.105 DBMET00648 | DBMET00648 | |
| 0.057 | 0.377 | 0.19 | NOS3 expression enhancer | 0.19 0.045 DBMET00648 | DBMET00648 | |
| 0.042 | 0.364 | 0.161 | Cyclooxygenase 3 inhibitor | 0.161 0.04 DBMET00648 | DBMET00648 | |
| 0.023 | 0.37 | 0.184 | Topoisomerase II inhibitor | 0.184 0.037 DBMET00648 | DBMET00648 | |
| 0.035 | 0.387 | 0.128 | Anticoagulant | 0.128 0.103 DBMET00648 | DBMET00648 | |
| 0.04 | 0.393 | 0.317 | Immunostimulant | 0.317 0.074 DBMET00648 | DBMET00648 | |
| 0.048 | 0.403 | 0.178 | DNA methylase inhibitor | 0.178 0.094 DBMET00648 | DBMET00648 | |
| 0.019 | 0.374 | 0.056 | Factor IXa inhibitor | 0.056 0.03 DBMET00648 | DBMET00648 | |
| 0.033 | 0.395 | 0.101 | DNA polymerase I inhibitor | 0.101 0.085 DBMET00648 | DBMET00648 | |
| 0.015 | 0.427 | 0.063 | Glucose-6-phosphate translocase inhibitor | 0.063 0.021 DBMET00648 | DBMET00648 | |
| 0.081 | 0.529 | 0.377 | Apoptosis agonist | 0.377 0.125 DBMET00648 | DBMET00648 | |
| 0.017 | 0.506 | 0.258 | Acetylcholinesterase inhibitor | 0.258 0.019 DBMET00648 | DBMET00648 | |
| 0.026 | 0.528 | 0.128 | Toll-Like receptor 4 antagonist | 0.128 0.037 DBMET00648 | DBMET00648 | |
| 0.011 | 0.52 | 0.061 | Antibiotic Aminoglycoside-like | 0.061 0.008 DBMET00648 | DBMET00648 | |
| 0.036 | 0.558 | 0.277 | Transcription factor NF kappa B inhibitor | 0.277 0.109 DBMET00648 | DBMET00648 | |
| 0.049 | 0.584 | 0.306 | Immunomodulator | 0.306 0.079 DBMET00648 | DBMET00648 | |
| 0.016 | 0.553 | 0.086 | Uric acid excretion stimulant | 0.086 0.071 DBMET00648 | DBMET00648 | |
| 0.032 | 0.626 | 0.352 | Immunosuppressant | 0.352 0.085 DBMET00648 | DBMET00648 | |
| 0.005 | 0.641 | 0.267 | Selectin antagonist | 0.267 0.007 DBMET00648 | DBMET00648 | |
| 0.017 | 0.664 | 0.214 | Nitric oxide antagonist | 0.214 0.063 DBMET00648 | DBMET00648 | |
| 0.017 | 0.679 | 0.136 | Insulin secretagoues | 0.136 0.09 DBMET00648 | DBMET00648 | |
| 0.012 | 0.682 | 0.212 | Cholinergic | 0.212 0.041 DBMET00648 | DBMET00648 | |
| 0.041 | 0.72 | 0.458 | Antiinflammatory | 0.458 0.107 DBMET00648 | DBMET00648 | |
| 0.013 | 0.704 | 0.443 | Angiogenesis stimulant | 0.443 0.016 DBMET00648 | DBMET00648 | |
| 0.027 | 0.737 | 0.303 | Hepatoprotectant | 0.303 0.029 DBMET00648 | DBMET00648 | |
| 0.024 | 0.746 | 0.098 | Transcription factor NF kappa B stimulant | 0.098 0.041 DBMET00648 | DBMET00648 | |
| 0.016 | 0.779 | 0.284 | Platelet adhesion inhibitor | 0.284 0.039 DBMET00648 | DBMET00648 | |
| 0.019 | 0.804 | 0.38 | Hypoglycemic | 0.38 0.031 DBMET00648 | DBMET00648 | |
| 0.009 | 0.818 | 0.106 | Cell adhesion inhibitor | 0.106 0.08 DBMET00648 | DBMET00648 | |
| 0.008 | 0.825 | 0.167 | Thrombolytic | 0.167 0.07 DBMET00648 | DBMET00648 | |
| 0.005 | 0.929 | 0.415 | Cyclophilin D inhibitor | 0.415 0.083 DBMET00648 | DBMET00648 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |